When it comes to preventing malaria, researchers and public health officials have been hopeful about the potential of a monoclonal antibody, one injection of which could provide recipients with several months of protection against the parasite. Such a tool, experts have thought, could give babies a layer of defense even before they start receiving doses of the malaria vaccines that have rolled out in recent years.
New research detailed Thursday has cast doubt on that strategy.